Evidence Repository - Clinical Genome Resources

The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

Variant: NM_000018.4(ACADVL):c.865G>A (p.Gly289Arg)

Curation Version - 1.0
Curation History
JSON LD for Version 1.0

CA8337873

370981 (ClinVar)

Gene: ACADVL

Condition: very long chain acyl-CoA dehydrogenase deficiency

Inheritance Mode: Autosomal recessive inheritance

Link to MONDO

UUID: 766653ae-7261-479b-91b4-683897d15917

Approved on: 2023-06-27

Published on: 2023-06-27

HGVS expressions

NM_000018.4:c.865G>A

NM_000018.4(ACADVL):c.865G>A (p.Gly289Arg)

NC_000017.11:g.7222289G>A

CM000679.2:g.7222289G>A

NC_000017.10:g.7125608G>A

CM000679.1:g.7125608G>A

NC_000017.9:g.7066332G>A

NG_007975.1:g.7456G>A

NG_008391.2:g.2762C>T

ENST00000356839.10:c.865G>A

ENST00000322910.9:c.*820G>A

ENST00000350303.9:c.799G>A

ENST00000356839.9:c.865G>A

ENST00000543245.6:c.934G>A

ENST00000577191.5:n.1037G>A

ENST00000581378.5:n.583G>A

ENST00000582379.1:n.249G>A

NM_000018.3:c.865G>A

NM_001033859.2:c.799G>A

NM_001270447.1:c.934G>A

NM_001270448.1:c.637G>A

NM_001033859.3:c.799G>A

NM_001270447.2:c.934G>A

NM_001270448.2:c.637G>A

Likely Pathogenic

PP3 PS3_Supporting PM2_Supporting PM3 PP4_Moderate

Evidence Links 0

Expert Panel

ACADVL VCEP

Criteria Specification Information

Criteria Specifications for this VCEP

Evidence submitted by expert panel

ACADVL VCEP

The c.865G>A (p.Gly289Arg) variant in ACADVL has been reported in the literature in patients with VLCADD and increased C14:1 acylcarnitine (PP4_moderate; PMID: 14517516, 23480858, 31031081, 32778825, 27209629). The variant has also been detected in compound heterozygote with truncating/pathogenic variants (PM3; PMID: 14517516, 23480858, 31031081). This variant is absent from gnomAD population database v2.1.1(PM2_Supporting). This variant causes significantly reduced enzyme activity (15% of WT) determined from a bacterial cell expression system and results in unstable protein product (PMID:23480858, PS3_supporting). The computational predictor REVEL gives a score of 0.824, which is above the threshold of 0.75, evidence that correlates with impact to ACADVL function (PP3). The ACADVL Variant Curation Expert Panel VCEP classified the variant as likely pathogenic based on (PS3_supporting, PM3, PM2_supporting, PP3, PP4_moderate).

PP3

REVEL = 0.824 (> 0.75)

PS3_Supporting

15% VLCAD activity from E.coli expressed. Unstable protein product.

PM2_Supporting

minor allele frequency (MAF) <0.001

PM3

2 patients with p.V243A 1 patient with p.I183Mfs* unknown phase points=1.5

PP4_Moderate

5 patient reports of VLCADD, including C14:1 range 1-3uM.

Curation History

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.